收费全文 | 20639篇 |
免费 | 1490篇 |
国内免费 | 35篇 |
耳鼻咽喉 | 129篇 |
儿科学 | 697篇 |
妇产科学 | 772篇 |
基础医学 | 2573篇 |
口腔科学 | 315篇 |
临床医学 | 3971篇 |
内科学 | 3758篇 |
皮肤病学 | 206篇 |
神经病学 | 2052篇 |
特种医学 | 295篇 |
外科学 | 1444篇 |
综合类 | 247篇 |
一般理论 | 31篇 |
预防医学 | 3008篇 |
眼科学 | 151篇 |
药学 | 1161篇 |
中国医学 | 13篇 |
肿瘤学 | 1341篇 |
2023年 | 112篇 |
2022年 | 79篇 |
2021年 | 323篇 |
2020年 | 242篇 |
2019年 | 382篇 |
2018年 | 426篇 |
2017年 | 344篇 |
2016年 | 408篇 |
2015年 | 489篇 |
2014年 | 671篇 |
2013年 | 1114篇 |
2012年 | 1409篇 |
2011年 | 1411篇 |
2010年 | 823篇 |
2009年 | 834篇 |
2008年 | 1390篇 |
2007年 | 1366篇 |
2006年 | 1362篇 |
2005年 | 1382篇 |
2004年 | 1327篇 |
2003年 | 1302篇 |
2002年 | 1247篇 |
2001年 | 167篇 |
2000年 | 135篇 |
1999年 | 191篇 |
1998年 | 259篇 |
1997年 | 203篇 |
1996年 | 197篇 |
1995年 | 228篇 |
1994年 | 198篇 |
1993年 | 179篇 |
1992年 | 150篇 |
1991年 | 140篇 |
1990年 | 124篇 |
1989年 | 110篇 |
1988年 | 108篇 |
1987年 | 109篇 |
1986年 | 83篇 |
1985年 | 89篇 |
1984年 | 120篇 |
1983年 | 94篇 |
1982年 | 126篇 |
1981年 | 113篇 |
1980年 | 107篇 |
1979年 | 63篇 |
1978年 | 71篇 |
1977年 | 54篇 |
1976年 | 55篇 |
1974年 | 41篇 |
1972年 | 29篇 |
Objective
To collaboratively implement the age-friendly health systems framework, known as the 4Ms: What Matters, Medication, Mentation, and Mobility, at The Primary Health Network (PHN), a federally qualified health center.Data Sources
Data were collected from PHN electronic medical records (EMRs) for individuals over age 65 from December 30, 2019 to December 24, 2021 and from Project ECHO© attendance and evaluation surveys.Study Design
The telementoring educational program, Project ECHO©, was used to engage PHN health care professionals working in rural areas of Pennsylvania to incorporate the 4Ms into their practice starting with the annual wellness visit (AWV). Project ECHO© was launched at three primary care sites. After 18 months, it was then disseminated to an additional 18 sites creating pilot and comparison groups. Outcomes included codesigned patient process metrics using EMR data and project ECHO© participant data.Data Collection Methods
EMR data were generated by system reports created by PHN's quality assurance program manager. Project ECHO© data were collected and managed using REDCap electronic data capture tools. Outcomes were aggregated, analyzed for trends over time, and compared between groups.Principal Findings
All nine process outcomes increased from baseline to follow-up at the three initial sites, ranging from 4% to 43% g. At year two, the three initial sites had higher rates on AWVs (pilot 24%, comparison 12%; p < 0.0001), Advance Care Planning (New on file, pilot 8%, comparison 2%; Discussed with patient, pilot 18%, comparison 13%; Patient declined, pilot 0%, comparison 0%; p = 0.0001), Dementia Screening (pilot 24%, comparison 12%; p < 0.0001), Fall Risk Management (pilot 43%, comparison 10%; p < 0.0001), and Mobility Goal (pilot 19%, comparison 9%; p < 0.0001); and lower rates on High-Risk Medication Elimination (pilot 54%, comparison, 63%, p < 0.02).Conclusions
Access to high-quality geriatric care for rural older adults can be improved by increasing health care professionals' knowledge of the 4Ms, beginning with its incorporation into the AWV. 相似文献Objective: The aim of this article is to summarize the impact of early and sustained treatment on the QoL and economic burden of aGHD by conducting a targeted literature review.
Methods: Standard electronic databases, including PubMed and the Cochrane collaboration website, were searched for publications between January 2006 and July 2016 for evidence of the humanistic and economic burden of aGHD. Search terms included growth hormone deficiency, health-related quality of life, HRQoL, patient-reported outcomes, outcome assessment, well-being and adherence.
Results: The literature search identified 732 initial hits and a final 14 publications were included. The analysis showed that the economic burden of aGHD is largely driven by the productivity losses associated with the disease. This is because most patients with aGHD are of working age and the QoL domains (memory & concentration and energy & vitality) most commonly affected by aGHD severely impair a person’s ability to work and may limit their contribution to society.
Conclusion: Untreated aGHD can seriously affect patients’ functioning. Early and continued treatment with GH replacement therapy could potentially improve the QoL and reduce the economic burden associated with aGHD. This review has limitations: only English language articles published since January 2006 were included and many of the studies were conducted in the Nordic countries; it is unclear how representative these studies are of the population as a whole. This was a literature review and not a systematic review, as it was thought to be unlikely that, in this rare disease, any additional publications would have been identified. Overall, this review reveals a paucity of data in this underserved population and points to research gaps which could be addressed with new studies. 相似文献